Shandong Lukang Pharmaceutical Co.,Ltd.’s Net Profit Dropped 7.8% in First Quarter of 2022

Shandong Lukang Pharmaceutical Co.,Ltd. (山东鲁抗医药股份有限公司) (600789.SH) reported a net profit of 45.7 million yuan in the first quarter of 2022, down 7.8% year-on-year.

Meanwhile, the company posted 1.3 billion yuan in revenue, up 1.8% year-on-year.

At the end of the reporting period, it had 8 billion yuan in total assets and 4.5 billion yuan in total liabilities, with a liability-to-asset ratio of 56.8%.